Compare SABS & NWFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SABS | NWFL |
|---|---|---|
| Founded | 2014 | 1870 |
| Country | United States | United States |
| Employees | 86 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.8M | 346.2M |
| IPO Year | N/A | 1996 |
| Metric | SABS | NWFL |
|---|---|---|
| Price | $3.37 | $32.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $10.75 | ★ $33.00 |
| AVG Volume (30 Days) | ★ 401.9K | 13.6K |
| Earning Date | 05-12-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 4.39% |
| EPS Growth | N/A | ★ 15150.00 |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | ★ $7,999,000.00 |
| Revenue This Year | N/A | $34.35 |
| Revenue Next Year | N/A | $5.55 |
| P/E Ratio | ★ N/A | $91.17 |
| Revenue Growth | N/A | ★ 8.11 |
| 52 Week Low | $1.65 | $23.70 |
| 52 Week High | $6.60 | $32.23 |
| Indicator | SABS | NWFL |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | 65.24 |
| Support Level | $2.84 | $28.95 |
| Resistance Level | $4.09 | N/A |
| Average True Range (ATR) | 0.17 | 0.71 |
| MACD | -0.02 | 0.22 |
| Stochastic Oscillator | 12.50 | 100.00 |
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.